ACADIA Pharmaceuticals Inc. ACAD NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

85/100

5/7 Pass

SharesGrow Intrinsic Value

ACADIA Pharmaceuticals Inc. (ACAD) has 20 알려진 내부자 및 기관 보유자 기록. 최대 보유자는 Baker Brothers Life Sciences LP 38,469,981 주 보유. 기타 주요 보유자에는 14159, L.P. 및 Adams Catherine Owen.

지난 12개월간 내부자는 45 건의 거래를 수행 ACAD 주식 — 12 건 매수 (평가액 $614.89K) 및 17 건 매도 (평가액 $2.73M). 내부자 매도가 매수를 초과했습니다.

ACAD 내부자 보유 현황

최대 보유자

Baker Brothers Life Sciences LP

38,469,981 주

매수 (12개월)

$614.89K 평가액

매도 (12개월)

$2.73M 평가액

12개월 거래 활동

매수 27%

매도 38%

내부자 주요 보유자

#	이름	직책	보유 주식수	최종 신고일	상대적 규모
1	Baker Brothers Life Sciences Lp	Director	38,469,981	2022-06-09	100%
2	14159, L.p.	10 Percent Owner	2,337,100	2016-01-08	6%
3	Adams Catherine Owen	Chief Executive Officer	353,261	2024-09-25	1%
4	Davis Stephen	CEO	173,520	2024-08-20	0%
5	Stankovic Srdjan R.	President	63,081	2022-11-22	0%
6	Williamson Douglas J	Executive VP, Research & Dev	50,655	2023-02-13	0%
7	Kim Austin D.	EVP,general Counsel, Secretary	46,901	2024-01-09	0%
8	Moore Terrence O	EVP, Chief Commercial Officer	33,750	2017-03-10	0%
9	Garner Thomas	EVP, Chief Commercial Officer	28,493	2026-03-10	0%
10	Baity Glenn	EVP and Gc	28,125	2018-04-20	0%
11	Baker Bros. Advisors Lp	10 Percent Owner	27,586	2025-06-02	0%
12	Owen Adams Catherine	Chief Executive Officer	26,444	2026-03-26	0%
13	Garofalo Elizabeth A.	Director	25,382	2025-09-03	0%
14	Schneyer Mark C.	EVP, Chief Financial Officer	24,414	2026-03-26	0%
15	Rhodes Jennifer J	EVP, Chief Legal Officer, Sec	15,124	2026-03-26	0%
16	Brege Laura	Director	15,095	2025-06-05	0%
17	Soland Daniel B	Director	13,059	2023-06-05	0%
18	Teehan Brendan	EVP, COO, Head of Commercial	9,913	2024-11-19	0%
19	Yang Michael J.	EVP and Cco	8,059	2021-01-08	0%
20	Thompson Elizabeth H.z.	EVP, Head of Research & Dev	6,715	2026-03-26	0%

최근 거래 (최근 12개월)

날짜	이름	직책	유형	주식수	주가	금액
2026-03-26	Schneyer Mark C.	EVP, Chief Financial Officer	정보 매도	37	$21.72	$803.54
2026-03-25	Schneyer Mark C.	EVP, Chief Financial Officer	옵션 행사 (매도)	6,178	-	-
2026-03-24	Schneyer Mark C.	EVP, Chief Financial Officer	옵션 행사 (매도)	8,138	-	-
2026-03-25	Thompson Elizabeth H.z.	EVP, Head of Research & Dev	정보 매도	3,435	$21.47	$73.75K
2026-03-24	Thompson Elizabeth H.z.	EVP, Head of Research & Dev	옵션 행사	6,715	-	-
2026-03-25	Owen Adams Catherine	Chief Executive Officer	정보 매도	11,641	$21.47	$249.93K
2026-03-24	Owen Adams Catherine	Chief Executive Officer	옵션 행사	23,509	-	-
2026-03-26	Kihara James	Principal Accounting Officer	정보 매도	12	$21.73	$260.70
2026-03-25	Kihara James	Principal Accounting Officer	옵션 행사 (매도)	2,142	-	-
2026-03-24	Kihara James	Principal Accounting Officer	옵션 행사 (매도)	1,627	-	-
2026-03-25	Rhodes Jennifer J	EVP, Chief Legal Officer, Sec	정보 매도	3,844	$21.47	$82.53K
2026-03-24	Rhodes Jennifer J	EVP, Chief Legal Officer, Sec	옵션 행사	7,515	-	-
2026-03-03	Poole Jonathan	Director	RSU 부여	2,010	-	-
2026-03-03	Poole Jonathan	Officer	알 수 없음	-	-	-
2026-03-06	Garner Thomas	EVP, Chief Commercial Officer	RSU 부여	28,493	-	-
2026-03-06	Schneyer Mark C.	EVP, Chief Financial Officer	RSU 부여	26,382	-	-
2026-03-06	Thompson Elizabeth H.z.	EVP, Head of Research & Dev	RSU 부여	29,548	-	-
2026-03-06	Owen Adams Catherine	Chief Executive Officer	RSU 부여	76,509	-	-
2026-03-06	Kihara James	Principal Accounting Officer	RSU 부여	6,332	-	-
2026-03-06	Rhodes Jennifer J	EVP, Chief Legal Officer, Sec	RSU 부여	26,382	-	-
2026-02-09	Rhodes Jennifer J	EVP, Chief Legal Officer, Sec	정보 매도	6,950	$23.38	$162.49K
2026-02-06	Rhodes Jennifer J	EVP, Chief Legal Officer, Sec	옵션 행사 (매도)	12,944	-	-
2025-11-18	Schneyer Mark C.	EVP, Chief Financial Officer	정보 매도	10,262	$23.69	$243.11K
2025-11-17	Schneyer Mark C.	EVP, Chief Financial Officer	옵션 행사 (매도)	9,913	-	-
2025-11-18	Kihara James	Principal Accounting Officer	정보 매도	4,084	$23.69	$96.75K